153 related articles for article (PubMed ID: 1976298)
1. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
Honsinger RW; Thomsen RJ
Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
Paul E; Bödeker RH
Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
Paul E; Bödeker RH
Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
[TBL] [Abstract][Full Text] [Related]
4. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
Sussman G; Jancelewicz Z
Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
[TBL] [Abstract][Full Text] [Related]
5. [Total review of all results collected worldwide with astemizole (Hismanal)].
Rombaut N; Vanden Bussche G
Z Hautkr; 1985; 60 Suppl 1():29-42. PubMed ID: 2859711
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
Cainelli T; Seidenari S; Valsecchi R; Mosca M
Pharmatherapeutica; 1986; 4(10):679-86. PubMed ID: 2885854
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile of astemizole. A survey of 50 double-blind trials.
Vanden Bussche G; Emanuel MB; Rombaut N
Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
[TBL] [Abstract][Full Text] [Related]
8. [Astemizole in urticaria--a multicenter study by 412 established dermatologists].
Kurz K; Oestreich W
Z Hautkr; 1987 Dec; 62(24):1724-32. PubMed ID: 2894098
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
Kurz K
Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic idiopathic urticaria with astemizole.
Huerter CJ; Bergfeld WF; Wagner WO; Dijkstra JW
Cleve Clin J Med; 1989 May; 56(3):263-6. PubMed ID: 2568189
[TBL] [Abstract][Full Text] [Related]
12. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
Emmi L; Rossi O
Minerva Med; 1988 Mar; 79(3):219-27. PubMed ID: 2896316
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
Oei HD
Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema.
Kailasam V; Mathews KP
J Am Acad Dermatol; 1987 Apr; 16(4):797-804. PubMed ID: 2883202
[TBL] [Abstract][Full Text] [Related]
15. Astemizole--another non-sedating antihistamine.
Med Lett Drugs Ther; 1989 May; 31(791):43-4. PubMed ID: 2565524
[No Abstract] [Full Text] [Related]
16. Astemizole in perennial allergic rhinitis with seasonal exacerbations: a placebo-controlled double-blind study.
Tanay A; Neuman I
Ann Allergy; 1989 Dec; 63(6 Pt 1):493-4. PubMed ID: 2574549
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
18. Astemizole--a new, non-sedating antihistamine for hayfever.
Knight A
J Otolaryngol; 1985 Apr; 14(2):85-8. PubMed ID: 2866257
[TBL] [Abstract][Full Text] [Related]
19. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
Molkhou P
Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
[TBL] [Abstract][Full Text] [Related]
20. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
